CEACAM5 and breast carcinoma: In addition, breast cancer antigens (BRCA), urokinase plasminogen activator (uPA), carcinoembryonic antigen (CEA), and cancer antigen (CA)15-3, are used as blood-based biomarkers in breast cancer (Duffy et al., 2017; Duffy et al., 2016).